1 study found for:    18519872 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed 12-Week, Double-Blind, Placeob-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/Carbodopa
Condition: Parkinson's Disease
Intervention: Drug: Istradefylline (KW-6002)

Indicates status has not been verified in more than two years